Iqbal Unnisa Ali

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
    I U Ali
    Division for Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, Bethesda, MD 20892, USA
    Br J Cancer 93:953-9. 2005
  2. ncbi request reprint Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers
    Iqbal Unnisa Ali
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    Oncol Rep 15:1367-72. 2006
  3. doi request reprint Altered gene expression profiles define pathways in colorectal cancer cell lines affected by celecoxib
    Naheed Fatima
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
    Cancer Epidemiol Biomarkers Prev 17:3051-61. 2008
  4. ncbi request reprint Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells
    Jianrong Lou
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 15:1598-606. 2006

Collaborators

Detail Information

Publications4

  1. pmc Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
    I U Ali
    Division for Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, Bethesda, MD 20892, USA
    Br J Cancer 93:953-9. 2005
    ..Our analysis underscores the significance of the overall allelic architecture of Cox-2 as an important determinant for risk assessment...
  2. ncbi request reprint Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers
    Iqbal Unnisa Ali
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    Oncol Rep 15:1367-72. 2006
    ..Validation of these biomarkers would have significant implications for the early detection of lung cancer and better management of high-risk patients...
  3. doi request reprint Altered gene expression profiles define pathways in colorectal cancer cell lines affected by celecoxib
    Naheed Fatima
    Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
    Cancer Epidemiol Biomarkers Prev 17:3051-61. 2008
    ..In the future, in-depth work on selected genes will determine if these genes may serve as potential molecular targets for more effective chemopreventive strategies...
  4. ncbi request reprint Proteomic profiling identifies cyclooxygenase-2-independent global proteomic changes by celecoxib in colorectal cancer cells
    Jianrong Lou
    Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 15:1598-606. 2006
    ..Our study presents a comprehensive analysis of large-scale celecoxib-modulated proteomic alterations, at least some of which may be mechanistically related to the COX-2-independent chemopreventive effect of celecoxib...